CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -44.4% | 3,742 | -24.4% | 0.00% | – |
| Q2 2022 | $9,000 | -96.8% | 4,948 | -96.4% | 0.00% | – |
| Q1 2022 | $277,000 | – | 137,037 | +13703600.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2021 | $724,000 | +46.9% | 103,170 | +0.6% | 0.00% | – |
| Q4 2020 | $493,000 | -33.6% | 102,570 | -19.5% | 0.00% | – |
| Q3 2020 | $743,000 | -77.4% | 127,370 | -73.8% | 0.00% | – |
| Q2 2020 | $3,283,000 | -12.5% | 486,370 | -17.6% | 0.00% | -100.0% |
| Q1 2020 | $3,753,000 | +75.5% | 590,070 | +187.6% | 0.00% | – |
| Q4 2019 | $2,139,000 | +54.7% | 205,170 | -41.7% | 0.00% | – |
| Q3 2019 | $1,383,000 | -80.7% | 352,074 | -26.8% | 0.00% | -100.0% |
| Q2 2019 | $7,150,000 | -67.9% | 480,825 | -46.4% | 0.00% | -66.7% |
| Q1 2019 | $22,272,000 | +19.2% | 897,343 | -13.8% | 0.00% | 0.0% |
| Q4 2018 | $18,687,000 | -47.2% | 1,040,495 | -13.6% | 0.00% | -25.0% |
| Q3 2018 | $35,366,000 | -48.3% | 1,204,147 | -20.0% | 0.00% | -50.0% |
| Q2 2018 | $68,400,000 | -5.4% | 1,504,304 | +9.8% | 0.01% | -11.1% |
| Q1 2018 | $72,312,000 | -52.2% | 1,369,555 | -38.5% | 0.01% | -50.0% |
| Q4 2017 | $151,344,000 | +5.0% | 2,225,642 | +27.2% | 0.02% | +5.9% |
| Q3 2017 | $144,180,000 | -11.1% | 1,749,761 | +1.0% | 0.02% | -15.0% |
| Q2 2017 | $162,259,000 | +40.3% | 1,732,981 | -4.6% | 0.02% | +33.3% |
| Q1 2017 | $115,679,000 | +432.4% | 1,816,859 | +271.4% | 0.02% | +400.0% |
| Q4 2016 | $21,728,000 | -4.0% | 489,156 | -22.1% | 0.00% | 0.0% |
| Q3 2016 | $22,631,000 | +123.8% | 627,756 | -14.8% | 0.00% | +200.0% |
| Q2 2016 | $10,114,000 | -63.3% | 737,156 | -48.7% | 0.00% | -75.0% |
| Q1 2016 | $27,580,000 | -71.1% | 1,436,456 | -47.3% | 0.00% | -69.2% |
| Q4 2015 | $95,456,000 | -69.8% | 2,727,310 | -20.6% | 0.01% | -71.1% |
| Q3 2015 | $315,853,000 | -0.7% | 3,434,675 | -5.1% | 0.04% | +9.8% |
| Q2 2015 | $318,055,000 | +3.3% | 3,619,195 | -12.8% | 0.04% | +5.1% |
| Q1 2015 | $307,939,000 | +42.5% | 4,148,445 | +7.5% | 0.04% | +39.3% |
| Q4 2014 | $216,138,000 | +29.6% | 3,859,599 | +5.0% | 0.03% | +21.7% |
| Q3 2014 | $166,745,000 | -15.9% | 3,676,026 | -23.2% | 0.02% | -14.8% |
| Q2 2014 | $198,311,000 | -43.7% | 4,788,976 | -5.8% | 0.03% | -44.9% |
| Q1 2014 | $352,233,000 | +23.3% | 5,084,935 | +7.3% | 0.05% | +22.5% |
| Q4 2013 | $285,578,000 | +5.8% | 4,738,308 | +6.7% | 0.04% | -2.4% |
| Q3 2013 | $269,991,000 | -9.2% | 4,442,108 | +0.1% | 0.04% | -16.3% |
| Q2 2013 | $297,376,000 | – | 4,439,762 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |